Sharechat Logo

Pacific Edge appoints Spark's Kate Rankin as CFO

Thursday 13th November 2014

Text too small?

Pacific Edge, the non-invasive bladder cancer test developer, has appointed Kate Rankin as its chief financial officer as it continues its push into overseas markets.

Rankin joins the Dunedin based biotech firm from Spark New Zealand, where she was senior finance performance manager and member of the international leadership team, the company said in a statement. She has also worked at Deutsche Bank as legal entity controller in London.

Pacific Edge's goal is to grow annual revenues to $100 million in the coming years. Much of the growth is expected to come from the US, with its non-invasive bladder cancer test, Cxbladder Detect, where it is securing healthcare provider trials. In New Zealand it provides the test through district health boards, and expects to launch its second product, Cxbladder Triage, later this year. In September the biotech firm announced plans to commercialise its Cxcolorectal test in Japan, where colorectal is the nation's most prevalent cancer,

"Kate will bring international business experience, finance and leadership skills to further build the capability of the Company’s senior management team," chief executive David Darling said. "Kate’s corporate business experience in the USA, Asia and UK will be of particular relevance as Pacific Edge looks to further commercialise its molecular diagnostic technology including Cxbladder, in those markets.”


Shares of Pacific Edge dropped 3.6 percent to 81 cents, more than half its February peak of $1.76. The stock is rated a 'buy' by Forsyth Barr, which has price target of $1.10.

Bond Offer: Infratil Ltd, 7.2 year & 10.2 year unsecured unsubordinated bond

  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

NZ dollar mixed, buffeted by Fed talk and downunder data
Super Fund can expect lower returns over next decade - review
ANALYSIS: Should penalties for continuous disclosure breaches be relaxed?
Fletcher seeks urgent talks on Ihumatao stalemate
NZ economy grows 0.5% in June quarter, beating expectations
Restaurant Brands lifts 2Q sales; appetite for KFC offsets ditched Starbucks
Auckland jet fuel arrangements a potential barrier to new entrants
NZ dollar weaker after Fed split on outlook for further US cuts
Leading judge says court administration model 'outdated'
MARKET CLOSE: NZ shares fall; Goodman placement sees property stocks sold

IRG See IRG research reports